CL · NYQ · Consumer Defensive
Colgate-Palmolive Company
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 82.66
Market price
USD 87.47
Implied upside
-5.5%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 21.3bn | USD 22.2bn | USD 23.1bn | USD 24.1bn | USD 25.1bn | +4.3% |
| EBIT | USD 4.4bn | USD 4.6bn | USD 4.8bn | USD 5.0bn | USD 5.2bn | +4.3% |
| NOPAT | USD 3.5bn | USD 3.7bn | USD 3.8bn | USD 4.0bn | USD 4.1bn | +4.3% |
| Add depreciation & amortisation | USD 640.3m | USD 667.8m | USD 696.4m | USD 726.3m | USD 757.5m | +4.3% |
| Less capital expenditure | USD -693.8m | USD -723.6m | USD -754.6m | USD -787.0m | USD -820.8m | +4.3% |
| Less increase in working capital | USD 467.4m | USD 487.5m | USD 508.4m | USD 530.3m | USD 553.0m | -4.3% |
| Free cashflow to firm | USD 3.9bn | USD 4.1bn | USD 4.3bn | USD 4.4bn | USD 4.6bn | +4.3% |
| Discount factor | 0.9642 | 0.8964 | 0.8334 | 0.7749 | 0.7204 | - |
| Present value | USD 3.8bn | USD 3.7bn | USD 3.6bn | USD 3.4bn | USD 3.3bn | -3.0% |
| Present Value Of The Forecast | USD 17.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.546 | Reported 0.323, pulled toward 1.0 (Blume) |
| Cost of equity | 8.00% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.00% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | USD 69.7bn | 89.1% of capital |
| Total debt | USD 8.6bn | 10.9% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 7.56% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
76% of EV
- Forecast FCFF, final year
- USD 4.6bn
- Capex at depreciation, working capital in reinvestment
- USD 4.1bn
- Less reinvestment at g/ROIC (6.5% of NOPAT)
- USD -269.7m
- Capitalised
- USD 3.9bn
- ROIC (reported)
- 38.4%
- Terminal value, undiscounted
- USD 78.5bn
- Terminal value, discounted
- USD 56.5bn
- Enterprise value
- USD 74.3bn
- Less net debt
- USD 7.3bn
- Equity value
- USD 67.0bn
Exit at 15.8x EBITDA
79% of EV
- Terminal value, undiscounted
- USD 95.1bn
- Terminal value, discounted
- USD 68.5bn
- Enterprise value
- USD 86.2bn
- Less net debt
- USD 7.3bn
- Equity value
- USD 79.0bn
Spread between methods: 16%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.56% | 110.20 | 122.76 | 139.41 | 162.53 | 196.86 |
| 6.56% | 87.45 | 94.85 | 104.06 | 115.84 | 131.46 |
| 7.56% | 72.19 | 76.96 | 82.66 | 89.60 | 98.23 |
| 8.56% | 61.24 | 64.50 | 68.29 | 72.76 | 78.10 |
| 9.56% | 52.99 | 55.33 | 57.98 | 61.03 | 64.59 |
Outlined: this model. Green text: above today's price of 87.47. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 4.3% | 5.3% | +1.0pp |
| EBIT margin | 20.9% | 22.0% | +1.1pp |
| Discount rate | 7.6% | 7.3% | -0.3pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.